OnabotulinumtoxinA for the treatment of neurogenic detrusor overactivity in children

AIMS: This study evaluated whether one (or more) of three doses of onabotulinumtoxinA were safe and effective to treat neurogenic detrusor overactivity (NDO) in children. METHODS: This was a 48‐week prospective, multicenter, randomized, double‐blind study in children (aged 5–17 years) with NDO and u...

Descripción completa

Detalles Bibliográficos
Autores principales: Austin, Paul F., Franco, Israel, Dobremez, Eric, Kroll, Pawel, Titanji, Wilson, Geib, Till, Jenkins, Brenda, Hoebeke, Piet B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Clinical Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839517/
https://www.ncbi.nlm.nih.gov/pubmed/33305474
http://dx.doi.org/10.1002/nau.24588

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7839517/
https://www.ncbi.nlm.nih.gov/pubmed/33305474
http://dx.doi.org/10.1002/nau.24588

Ejemplares similares